tethered chemerin 9



tethered chemerin 9

M1MM1S2SS2T3TT3E4EE4S5SS5M6MM6I7II7R8RR8D9DD9V10VV10E11EE11L12LL12A13AA13E14EE14E15EE15A16AA16L17LL17P18PP18K19KK19K20KK20T21TT21G22GG22G23GG23P24PP24Q25QQ25G26GG26S27SS27R28RR28R29RR29C30CC30L31LL31F32FF32L33LL33S34SS34L35LL35F36FF36S37SS37F38FF38L39LL39I40II40V41VV41A42AA42G43GG43A44AA44T45TT45T46TT46L47LL47... and 61 more residue(s)...... and 61 more residue(s)

SMILES None
InChIKey None
Sequence MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAGATTLFCLLHFGVIGSGNGNGNGNGNGNGNGNGNGNEQKLISEEDLGNGNGNGSGNSYFPGQFAFS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

tethered chemerin 9

M1MM1S2SS2T3TT3E4EE4S5SS5M6MM6I7II7R8RR8D9DD9V10VV10E11EE11L12LL12A13AA13E14EE14E15EE15A16AA16L17LL17P18PP18K19KK19K20KK20T21TT21G22GG22G23GG23P24PP24Q25QQ25G26GG26S27SS27R28RR28R29RR29C30CC30L31LL31F32FF32L33LL33S34SS34L35LL35F36FF36S37SS37F38FF38L39LL39I40II40V41VV41A42AA42G43GG43A44AA44T45TT45T46TT46L47LL47... and 61 more residue(s)...... and 61 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.